Mutations in the melanocortin-3 receptor (MC3R) gene: Impact on human obesity or adiposity

Current Opinion in Investigational Drugs

Volumn 11, Issue 10, 2010, Pages 1092-1096

  Tao, Y X ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 3 RECEPTOR;

BODY MASS; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENERGY BALANCE; GENE; GENE MUTATION; HOMEOSTASIS; HUMAN; NONHUMAN; OBESITY; PATHOGENESIS; PHENOTYPE; REVIEW;

ADIPOSITY; ANIMALS; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; OBESITY; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 3;

EID: 77957600847     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ et al: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell (1997) 88(1):131-141.
2. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM et al: Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell (2005) 123(3): 493-505.
3. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM et al: Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet (2000) 26(1):97-102.
4. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD: A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology (2000) 141(9): 3518-3521.
5. Zhang Y, Kilroy GE, Henagan TM, Prpic-Uhing V, Richards WG, Bannon AW, Mynatt RL, Gettys TW: Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin. FASEB J (2005) 19(11): 1482-1491.
6. Farooqi IS, O'Rahilly S: Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Nat Clin Pract Endocrinol Metab (2008) 4(10):569-577.
7. Tao YX: The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology. Endocr Rev (2010) 31(4):506-543.
8. Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, Bouchard C: Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest (1997) 100(5):1240-1247.
9. Zouali H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F, Froguel P: A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet (1997) 6(9):1401-1408.
10. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS: New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes (1997) 46(5):876-881.
11. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB, Akots G, Rich SS, Freedman BI: Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes (1997) 46(5):882-886.
12. Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, Erdos MR, Langefeld CD, Balow J Jr, Ally DS, Kohtamaki K, Chines P et al: Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci USA (1999) 96(5):2198-2203.
13. Li WD, Joo EJ, Furlong EB, Galvin M, Abel K, Bell CJ, Price RA: Melanocortin 3 receptor (MC3R) gene variants in extremely obese women. Int J Obes Relat Metab Disord (2000) 24(2): 206-210.
14. Hani EH, Dupont S, Durand E, Dina C, Gallina S, Gantz I, Froguel P: Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J Clin Endocrinol Metab (2001) 86(6):2895-2898.
15. Wong J, Love DR, Kyle C, Daniels A, White M, Stewart AW, Schnell AH, Elston RC, Holdaway IM, Mountjoy KG: Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes. Diabetes Res Clin Prac (2002) 58(1):61-71.
16. Boucher N, Lanouette CM, Larose M, Perusse L, Bouchard C, Chagnon YC: A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol Med (2002) 8(3):158-165.
17. Schalin-Jantti C, Valli-Jaakola K, Oksanen L, Martelin E, Laitinen K, Krusius T, Mustajoki P, Heikinheimo M, Kontula K: Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord (2003) 27(1):70-74.
18. Feng N, Young SF, Aguilera G, Puricelli E, Adler-Wailes DC, Sebring NG, Yanovski JA: Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes (2005) 54(9):2663-2667.
19. Lee YS, Poh LK, Loke KY: A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab (2002) 87(3):1423-1426.
20. Lee YS, Poh LK, Kek BL, Loke KY: The role of melanocortin 3 receptor gene in childhood obesity. Diabetes (2007) 56(10): 2622-2630.
21. Mencarelli M, Walker GE, Maestrini S, Alberti L, Verti B, Brunani A, Petroni ML, Tagliaferri M, Liuzzi A, Di Blasio AM: Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur J Hum Genet (2008) 16(5):581-586.
22. Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, Pullinger CR, Bromberg Y, Pennacchio LA, Dent R, McPherson R, Ahituv N et al: Association of functionally significant melanocortin-4 but not melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum Mol Genet (2009) 18(6):1140-1147.
23. Zegers D, Beckers S, de Freitas F, Peeters AV, Mertens IL, Verhulst SL, Rooman RP, Timmermans JP, Desager KN, Massa G, Van Gaal LF et al: Identification of three novel genetic variants in the melanocortin-3 receptor of obese children. Obesity (Silver Spring) (2010):doi:10.1038/oby.2010.127.
24. Tao YX, Segaloff DL: Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J Clin Endocrinol Metab (2004) 89(8):3936-3942.
25. Rached M, Buronfosse A, Begeot M, Penhoat A: Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim Biophys Acta (2004) 1689(3):229-234.
26. Tao YX: Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol (2005) 239(1-2):1-14.
27. Tao YX: Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim Biophys Acta (2007) 1772(10):1167-1174.
28. Tao YX, Segaloff DL: Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology (2003) 144(10):4544-4551.
29. Tao YX: Mutations in melanocortin-4 receptor and human obesity. Prog Mol Biol Transl Sci (2009) 88:173-204.
30. Tao YX, Segaloff DL: Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. J Clin Endocrinol Metab (2005) 90(10):5632-5638.
31. Muller MJ, Bosy-Westphal A, Krawczak M: Genetic studies of common types of obesity: A critique of the current use of phenotypes. Obes Rev (2010) 11(8):612-618.
32. Stutzmann F, Tan K, Vatin V, Dina C, Jouret B, Tichet J, Balkau B, Potoczna N, Horber F, O'Rahilly S, Farooqi IS et al: Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes (2008) 57(9):2511-2518.